End-of-year earnings reports reveal drugmakers are grappling with declining vaccination rates and an unpredictable Trump administration.
Challenges mount for vaccine makers
End-of-year earnings reports reveal drugmakers are grappling with declining vaccination rates and an unpredictable Trump administration.
